leadership1 publisher
Biopharma buyers put a contingent payout in more than half of 2025's public deals
Sidley Austin counts 28 contingent value rights across 59 announced public life sciences deals last year, a record share, with the contingent piece averaging 39% of the upfront price. The first half of 2026 ran near half that rate.
Publishers:corpgov.law.harvard.edu
Reality
- Evidence62
- Adoption80
- Hype gap+18
- Incentives68
- Confidence64